AU2003254631A1 - Test systems for detecting inhibitors of inositol phosphate kinases and use of these inhibitors for the prophylaxis or therapy of proliferative diseases - Google Patents

Test systems for detecting inhibitors of inositol phosphate kinases and use of these inhibitors for the prophylaxis or therapy of proliferative diseases

Info

Publication number
AU2003254631A1
AU2003254631A1 AU2003254631A AU2003254631A AU2003254631A1 AU 2003254631 A1 AU2003254631 A1 AU 2003254631A1 AU 2003254631 A AU2003254631 A AU 2003254631A AU 2003254631 A AU2003254631 A AU 2003254631A AU 2003254631 A1 AU2003254631 A1 AU 2003254631A1
Authority
AU
Australia
Prior art keywords
inhibitors
prophylaxis
therapy
proliferative diseases
test systems
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003254631A
Other languages
English (en)
Other versions
AU2003254631A8 (en
Inventor
Kirsten Hillemeier
Georg W. Mayr
Marcus M. Nalaskowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEDLNNOVA GESELLSCHAFT fur MEDIZINISCHE INNOVATIONEN AUS AKADEMISCHER FORSCHUNG MBH
Original Assignee
MEDLNNOVA GES fur MEDIZINISCHE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEDLNNOVA GES fur MEDIZINISCHE filed Critical MEDLNNOVA GES fur MEDIZINISCHE
Publication of AU2003254631A8 publication Critical patent/AU2003254631A8/xx
Publication of AU2003254631A1 publication Critical patent/AU2003254631A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003254631A 2002-07-16 2003-07-16 Test systems for detecting inhibitors of inositol phosphate kinases and use of these inhibitors for the prophylaxis or therapy of proliferative diseases Abandoned AU2003254631A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10232723.8 2002-07-16
DE2002132723 DE10232723A1 (de) 2002-07-16 2002-07-16 Testsystem zur Auffindung von Inhibitoren von Inositolphosphatkinasen und Verwendungen dieser Inhibitoren für die Prophylaxe oder Therapie von proliferativen Erkrankungen
PCT/DE2003/002440 WO2004009833A2 (de) 2002-07-16 2003-07-16 Testsysteme zur auffindung von inhibitoren von inositolphosphatkinasen und verwendung dieser inhibitoren für die prophylaxe oder therapie von proliferativen erkrankungen

Publications (2)

Publication Number Publication Date
AU2003254631A8 AU2003254631A8 (en) 2004-02-09
AU2003254631A1 true AU2003254631A1 (en) 2004-02-09

Family

ID=30010184

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003254631A Abandoned AU2003254631A1 (en) 2002-07-16 2003-07-16 Test systems for detecting inhibitors of inositol phosphate kinases and use of these inhibitors for the prophylaxis or therapy of proliferative diseases

Country Status (3)

Country Link
AU (1) AU2003254631A1 (de)
DE (1) DE10232723A1 (de)
WO (1) WO2004009833A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004066926A2 (en) * 2003-01-25 2004-08-12 Irm Llc Methods and compositions for modulating t lymphocytes

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648214A (en) * 1990-06-11 1997-07-15 University Research Corporation High-affinity oligonucleotide ligands to the tachykinin substance P
US5385936A (en) * 1990-07-12 1995-01-31 The United States Of America As Represented By The Secretary Of The Department Of The Health And Human Services Gossypol acetic acid for the treatment of cancer
DE69103503T2 (de) * 1990-09-28 1995-01-05 Mercian Corp Adriamycinderivate.
DE4432771A1 (de) * 1994-09-14 1996-03-21 Landesvereinigung Der Bayerisc Testmedium für einen mikrobiologischen Hemmstofftest und Verfahren zu seiner Durchführung
GB9611460D0 (en) * 1996-06-01 1996-08-07 Ludwig Inst Cancer Res Novel lipid kinase
DE19819889A1 (de) * 1998-05-04 1999-11-11 Fraunhofer Ges Forschung Verfahren zur Isolierung von Nucleinsäuren
EP1075546A1 (de) * 1998-05-04 2001-02-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren und vorrichtung zur isolierung von nukleinsäuren
US6100090A (en) * 1999-06-25 2000-08-08 Isis Pharmaceuticals Inc. Antisense inhibition of PI3K p85 expression
DE19837758A1 (de) * 1998-08-20 2000-02-24 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus Flavonoiden und UV-Filtersubstanzen als antivirales Wirkprinzip
KR20000019718A (ko) * 1998-09-15 2000-04-15 박호군 탄닌 또는 탄닌 유래 페놀성 화합물을 포함하는 동맥경화증, 고지혈증 및 간질환의 예방 및 치료용 조성물

Also Published As

Publication number Publication date
AU2003254631A8 (en) 2004-02-09
WO2004009833A2 (de) 2004-01-29
DE10232723A1 (de) 2004-02-05
WO2004009833A3 (de) 2004-12-02

Similar Documents

Publication Publication Date Title
AU2003206785A1 (en) Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
WO2001044247A3 (en) Agents and methods for the treatment of proliferative diseases
AU2003243318A1 (en) Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer
HK1139036A1 (en) Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
HUP0500101A3 (en) Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
IL173035A0 (en) 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (p13) for the treatment of inflammatory airway diseases
AU2002310187A1 (en) Inhibitors of protein kinase for the treatment of disease
WO2002030353A3 (en) NF-λB INHIBITORS
AU2003223380A1 (en) Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
AU2003300454A1 (en) Method and device for the three-dimensional measurement of objects
AU2003242860A1 (en) 2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders
EP1812432A4 (de) Kombination eines src-kinase-inhibitors und eines bcr-abl-inhibitors zur behandlung von proliferativen krankheiten
HK1079220A1 (en) Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases cd83
AU2002252227A1 (en) Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
TW200505443A (en) Combination of SCR kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
AU2003270037A1 (en) Methods for measuring kinase activity and phosphatase activity
TW200508233A (en) Chk-1 inhibitors
AU2003299378A1 (en) Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases
AU2003292643A1 (en) Equipment for measuring distribution of void or particle size
AU2003254631A1 (en) Test systems for detecting inhibitors of inositol phosphate kinases and use of these inhibitors for the prophylaxis or therapy of proliferative diseases
AU2003214560A1 (en) Test for measurement of therapeutic drug levels
WO2001044235A3 (en) Agents and methods for the treatment of proliferative diseases
PL369736A1 (en) New medicinal compositions on the basis of anticholinergic agents and egfr kinase inhibitors
AU2003222252A1 (en) Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases
AU2003216706A1 (en) Device for measurement of tissue hardness

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase